Mepitel, Mepilex, and Mepilex Border (Molnlycke Health Care) feature a unique dressing technology called "Safetac." These products are silicone based which results in decreased trauma and pain ...

"Why did my classmate say that my skin is yucky?" asked five-year-old Sophie Goh. It may seem like an innocent question, but ...

Krystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation. Read why KRYS ...

LEO Pharma and Reig Jofre have entered into a partnership aimed at improving access to LEO’s psoriasis treatment in Europe.

Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic Dermatitis; ...

Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, ...

Q4 2024 Earnings Call Transcript March 27, 2025 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.4, ...

A Cardiff-based cell orchestration company is set to see a multibillion-dollar boost to its turnover after acquiring a string of new clients in the US.

Analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Abeona Therapeutics in a research ...

Q4 2024 Management View CEO Raymond Tesi highlighted the transformative potential of 2024 for INmune Bio, emphasizing upcoming milestones. He noted the Phase 2 trial of XPro for Alzheimer's disease, ...